view solid result volatil market nice proof point msci
resili calmer equiti market start give us confid abil
continu outperform market us biggest posit steadi
strength index subscript franchis run-rat recur sale
fact manag will get aggress capit
alloc take advantag rare stock pullback buyback
asset-bas fee turn neg run-rat
healthi inflow quarter accentu secular tailwind support
busi outsid analyt organ subscript esg
estat show modest sequenti deceler remain healthi
grower absolut term manag note continu strength sell
environ notic chang client behavior healthi pipelin
final term guidanc ebitda expens growth assum
roughli flattish/choppi equiti market view posit sign
even number growth opportun esg factor analyt platform fix
incom pe/r prudent layer invest also fund
chang busi invest run busi efficiencies/sav
reiter ow rate sign better backdrop equiti market acwi ex-
us ytd rais pt prior ep
long-term see beneficiari secular active-to-pass esg
altern invest trend believ resili mani appreci
index subscript grew flow etf
consist posit coupl analyt rejuven buyback
provid support share note next potenti catalyst
investor day expect manag lay new segment growth/margin
target along typic educ deep dive next growth opportun
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
prior pt base prior ep estim
overweight top qualiti financi info
servic compani blue-chip franchis
ldd organ grower margin
analyt busi show strong
momentum believ mid multipl
warrant combin top-lin growth
margin expans deliv
secular trend continu work favor
drive ep higher estim
assum ep get valuat
subscript mix faster asset-bas fee
off-set especi fee pressur weak
market ep could lower de-
rate multipl get valuat
compani report refinitiv streetaccount consensu barclay research
estimateconsensu estimatetot organ performanceactualreportedbarclay revenu diff y/yrecur adjust revenuesanalyt adjust revenuesoth adjust diff y/i diff subscript revenues/run-r strong growth core product custom special index product factor/esg product growth asset owner hf wealth manag segment- asset-bas fee revenues/run-r revenu growth driven non-etf passiv fund exchang trade futures/opt partial off-set revenu etf product term revenu non-etf futures/opt etf non-recur revenu growth driven growth licens fee associ use index over-the-counter derivatives- averag basi point fee etf vs last year driven product mix revenu ex divestitur rate growth equiti analyt product time client implementations- revenu esg esg driven strong growth esg rate benefit increas invest driven growth enterpris analyt market inform product ex-fx growth esg run rate ex fx esg ex fx estat ex fx commentari recur subscript revenu asset-bas fee non-recur organ subscript run-rat analyt retent rate y/y- compens benefit cost increas incent comp wage salari partial off-set decreas sever costs- non-comp increas profession fee market cost costs- headcount em- repurchas share per share total tax rate barclay inc
guidanc number
guidanc number
guidanc barclay estimatespreviousestimatesconsensusestimatestot oper ebitda expens flow includ expens tax tax rate adj tax vest multi-year gross pay-out adj ebitda expens double-digit double-digitmid-to-upp singl digit barclay inc
manav patnaik herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
